AVENUE THERAPEUTICS INC's ticker is and the CUSIP is 05360L304. A total of 15 filers reported holding AVENUE THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 670,926 | $98,962 | 0.06% |
| WELLS FARGO & COMPANY/MN | 4,801 | $709 | 0.00% |
| JANE STREET GROUP, LLC | 29,937 | $4,416 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 52,160 | $7,693 | 0.00% |
| EMFO, LLC | 533 | $79 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 10,501 | $1,549 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 71,947 | $10,612 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 178,025 | $26,259 | 0.00% |
| JPMORGAN CHASE & CO | 5 | $1 | 0.00% |
| HRT FINANCIAL LP | 46,227 | $6 | 0.00% |
| Tower Research Capital LLC (TRC) | 8,872 | $1,313 | 0.00% |
| STATE STREET CORP | 30,593 | $4,512 | 0.00% |
| ROYAL BANK OF CANADA | 554 | $0 | 0.00% |
| VANGUARD GROUP INC | 46,293 | $6,828 | 0.00% |
This page lists AVENUE THERAPEUTICS INC's shareholders in Q1 2024. To view AVENUE THERAPEUTICS INC's shareholder history, click here.